Bristol Myers Squibb Stock Price on November 19, 2024
| BMYMP Stock | USD 1,006 0.00 0.00% |
If you're considering investing in Bristol-Myers Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Bristol-Myers Squibb stands at 1,006, as last reported on the 26th of November, with the highest price reaching 1,006 and the lowest price hitting 1,006 during the day. Bristol-Myers Squibb appears to be very steady, given 3 months investment horizon. Bristol Myers Squibb secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. We have found eighteen technical indicators for Bristol Myers Squibb, which you can use to evaluate the volatility of the firm. Please makes use of Bristol-Myers Squibb's Standard Deviation of 3.39, mean deviation of 1.49, and Risk Adjusted Performance of 0.1111 to double-check if our risk estimates are consistent with your expectations.
Bristol-Myers Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Bristol-Myers |
Sharpe Ratio = 0.1238
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BMYMP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.5 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Bristol-Myers Squibb is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bristol-Myers Squibb by adding it to a well-diversified portfolio.
Related Headline
GlaxoSmithKline PLC Headline on 19th of November 2024
GSKs phase III trial of linerixibat shows promise for PBC it... by investing.com
GSKs phase III trial of linerixibat shows promise for PBC itch
Bristol-Myers Squibb Valuation on November 19, 2024
It is possible to determine the worth of Bristol-Myers Squibb on a given historical date. On November 19, 2024 Bristol-Myers was worth 1005.55 at the beginning of the trading date compared to the closed value of 1005.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bristol-Myers Squibb pink sheet. Still, in general, we apply an absolute valuation method to find Bristol-Myers Squibb's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bristol-Myers Squibb where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bristol-Myers Squibb's related companies.
| Open | High | Low | Close | Volume | |
| 1,006 | 1,006 | 1,006 | 1,006 | 1.00 | |
11/19/2024 | 1,006 | 1,006 | 1,006 | 1,006 | 3.00 |
| 1,006 | 1,006 | 1,006 | 1,006 | 1.00 |
| Backtest Bristol-Myers Squibb | | | Bristol-Myers Squibb History | | | Bristol-Myers Squibb Valuation | Previous | Next |
Bristol-Myers Squibb Trading Date Momentum on November 19, 2024
| On November 20 2024 Bristol Myers Squibb was traded for 1,006 at the closing time. The highest daily price throughout the period was 1,006 and the lowest price was 1,006 . There was no trading activity during the period 1.0. Lack of trading volume on 11/20/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Bristol Myers Squibb Fundamentals Correlations and Trends
By evaluating Bristol-Myers Squibb's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bristol-Myers Squibb's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bristol-Myers financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bristol-Myers Squibb Pink Sheet history
Bristol-Myers Squibb investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bristol-Myers is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bristol Myers Squibb will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bristol-Myers Squibb stock prices may prove useful in developing a viable investing in Bristol-Myers Squibb
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.
Bristol-Myers Squibb Pink Sheet Technical Analysis
Bristol-Myers Squibb technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Bristol-Myers Squibb Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Bristol Myers Squibb cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bristol-Myers Squibb November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Bristol-Myers Squibb pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bristol-Myers Squibb shares will generate the highest return on investment. By undertsting and applying Bristol-Myers Squibb pink sheet market strength indicators, traders can identify Bristol Myers Squibb entry and exit signals to maximize returns
Bristol-Myers Squibb Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bristol-Myers Squibb's price direction in advance. Along with the technical and fundamental analysis of Bristol-Myers Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bristol-Myers to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1111 | |||
| Jensen Alpha | 0.4213 | |||
| Total Risk Alpha | (0.08) | |||
| Treynor Ratio | 1.99 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Bristol-Myers Pink Sheet Analysis
When running Bristol-Myers Squibb's price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.